Advances in Urology / 2012 / Article / Tab 2

Clinical Study

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer

Table 2

Patient’s characteristics for all patients and according to prescription group.

CharacteristicPrescription group
All ( )74R72 ( )76R74 ( )78R76 ( )

Age (years)66 (41–79)62 (51–76)65 (53–75)66 (41–79)
Followup (months)48 (24–132)60 (24–132)84 (24–108)45 (24–96)
PSA level (ng/mL)19 (4–302)26 (8–150)20 (4–90)14 (4–302)
Gleason score
 2–649 (39)9 (43)11 (58)29 (34)
 7 (3 + 4)/(4 + 3)37 (29)7 (33)5 (26)25 (29)
 8–1039 (31)5 (24)3 (16)31 (36)
 Unknown1 (1)1 (1)
Tumor stage
 T117 (13)2 (10)4 (20)11 (12)
 T240 (32)9 (43)2 (11)29 (34)
 T360 (48)7 (33)12 (64)40 (48)
 T49 (7)3 (14)1 (5)6 (6)
Node stage
 pN054 (43)9 (43)3 (16)42 (49)
Androgen deprivation
 Yes116 (92)14 (67)17 (89)85 (99)
 No10 (8)7 (33)2 (11)1 (1)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.